ResearcherUniversity of Wisconsin–MadisonNo recent work listed

Kyle Holen

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 6 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 1
Grants: 0
Labs led: 0
Collaborators: 1

Trials 1

Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors Study chair NCT00227773 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mary F. Mulcahy · 1 shared trial · strength 0.19
- Trial Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors NCT00227773 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.